Liver International · 2021 · 42 citations · 15 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationTransplant ImmunologyVaccinologyImmune ResponseImmune Response To VaccinationLiver Transplant ImmunosuppressionVaccinationVaccine EfficacyAntibodiesImmunosuppressive Drug TherapyMessenger Rna (Mrna) VaccinesMycophenolate-based ImmunosuppressionT Cell-mediated Immune ResponseT-cell Mediated Immune ResponseT-cell Mediated ResponsesVaccination In Transplant Recipients
Limited data are available on risks and benefits of anti-SARS-CoV2 vaccination in solid organ transplant recipients, and weaker responses have been described. At the Italian National Institute for Infectious Diseases, 61 liver transplant recipients underwent testing to describe the dynamics of humoral and cell-mediated immune response after two doses of anti-SARS-CoV2 mRNA vaccines and compared with 51 healthy controls. Humoral response was measured by quantifying both anti-spike and neutralizing antibodies; cell-mediated response was measured by PBMC proliferation assay with IFN-γ and IL-2 production. Liver transplant recipients showed lower response rates compared with controls in both humoral and cellular arms; shorter time since transplantation and multi-drug immunosuppressive regimen containing mycophenolate mofetil were predictive of reduced response to vaccination. Specific antibody and cytokine production, though reduced, were highly correlated in transplant recipients.
15
Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study
Olivia S. Kates, Brandy Haydel, Sander Florman et al. · Clinical Infectious Diseases · 2020 · 406 citations · Full text